Diabetes, Metabolic Syndrome and Obesity (Nov 2020)
Network Pharmacology Combined with Transcriptional Analysis to Unveil the Biological Basis of Astaxanthin in Reducing the Oxidative Stress Induced by Diabetes Mellitus
Abstract
Xueliang Sun,1,2 Yanbin Ji,2 Ayesha Tahir,3 Jun Kang1 1School of Life Sciences, Tianjin University, Tianjin 300072, People’s Republic of China; 2Tianjin Key Laboratory of Aquaecology and Aquaculture, College of Fisheries, Tianjin Agricultural University, Tianjin 300384, People’s Republic of China; 3Department of Biosciences, COMSATS University Islamabad, Islamabad 45550, PakistanCorrespondence: Ayesha TahirDepartment of Biosciences, COMSATS University Islamabad, Park Road, Islamabad 45550, PakistanEmail [email protected] KangSchool of Life Sciences, Tianjin University, 92 Weijin Road, Nankai District, Tianjin 300072, People’s Republic of China, Tel +86-22-2740-1060Email [email protected]: Astaxanthin (Ast) has been reported to reduce oxidative stress induced by diabetes mellitus (DM). The aim of this research was to give a systematic overview of the biological basis for this process.Methods: Ast-targeted proteins were collected from the BATMAN database, Comparative Toxicogenomics Database, and STITCH database. Putative DM-related protein targets were collected from the GeneCards database. A DM-rat model was then built with streptozotocin (STZ) combined with a high-sugar, high-fat diet for 30 days. Total cholesterol (TC), triglycerides (TGs), and insulin levels were examined using whole tail-vein blood from overnight-fasted rats. SOD, GSH, and MDA activy was detected in liver tissue (p< 0.05). In addition, we used RNA-sequencing analysis to detect gene-transcription level in liver tissue of rats and GO biological process analysis to show all the log2FC≥ 2 genes in the Ast-fed DM rats compared with the DM group using the STRING database. Ast-intersecting targets were collected with Venn analysis. Docking analysis between Ast and targeted proteins was down with the SwissDock server. Ast targets–pathway networks were built using Cytoscape 3.7.2 software.Results: A total of 120 Ast-targeted proteins and 13,784 DM-related targets were collected. Ast functioned in reducing TC, TG, and MDA levels, promoting SOD activity and GSH expression, and alleviating islet-cell injury in Ast-fed DM rats compared with DM control rats. Furthermore, genes involved in MAPK, TNF, AMPK, and FOXO signaling pathways were differently expressed in Ast-treated DM rats compared with DM rats. The differentially expressed genes were enriched in euchromatin, thyroid cancer, and metaphase-plate congression. Three Ast-intersecting targets — Col5A1, Nqo1, and Notch2 — were then identified. We found possible binding patterns of Ast with Nqo1 and Notch2, respectively. Ast targets–pathway networks were finally built to show a systematic overview of how Ast works in multiple pathways to reduce oxidative stress. Taken together, Ast is predicted to target Col5A1, Nqo1, and Notch2 to form a network of systemic pharmacological effects to: 1) promote insulin-releasing balance and relieve insulin resistance, 2) reduce testicular cell apoptosis, and 3) maintain normal size in marginal-zone B cells and inhibit autoimmune DM, all of which contribute to the balance of lipid metabolism and reduction of oxidative stress in DM patients.Conclusion: Ast functions in reducing oxidative stress in DM rats by regulating a variety of targets to form a comprehensive antioxidative network.Keywords: astaxanthin, diabetes mellitus, oxidative stress, RNA-seq analysis, network pharmacy